About this trial
This study compares the results of the existing fibrinogen concentration monitoring technology to the Electrochemical-based device, a point-of-care and rapid method,using a small amount of extra blood obtained in Type A Aortic Dissection Surgery.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
Participants for this study will be recruited at the Second Affiliated Hospital Zhejiang University School of Medicine. For part 1:The study participants will be adult underwent routine hemostasis analysis. For part 2:The study participants will be adult underwent surgery for acute type A aortic dissection and requires routine TEG test, residual blood samples collected for fibrinogen detection by the Clauss method and electrochemical method.
Trial design
Other
Prospective
Treatments tested in this trial
the Electrochemical-based device
Diagnostic testElectrochemical-based device for rapid detection of fibrinogen is a novel POC diagnostic method, which is suitable for operating theatres and emergency rooms.
Treatment groups
Trial outcomes
Primary outcomes
The fibrinogen concentration values obtained using the Clauss method and electrochemical method were compared
Secondary outcomes
the time of the two detection methods
Sponsors and contacts
Click on the lead sponsor to view all of their trials.